Literature DB >> 730076

Plasma ratio of valine, leucine and isoleucine to phenylalanine and tyrosine in liver disease.

M Y Morgan, J P Milsom, S Sherlock.   

Abstract

The molar ratio valine + leucine + isoleucine/phenylalanine + tyrosine was determined in the plasma of patients with liver disease of varying aetiology and severity and in an age and sex matched control group. In the control group of 58 subjects the mean ratio was 3.3 +/- 0.5 (ISD). The mean ratio was significantly lowered in groups of 25 patients with alcoholic cirrhosis (P less than 0.001), 25 patients with chronic active hepatitis (P less than 0.001), 23 patients with primary biliary cirrhosis (P less than 0.001), and 11 patients with cryptogenic cirrhosis (P less than 0.001). In a group of 50 patients with cirrhosis, the ratio was significantly lowered (P less than 0.001) irrespective of the presence of hepatic encephalopathy. A good correlation existed between the value of the ratio and the severity of the liver disease as judged histologically, with values of the ratio appearing to reflect histological change irrespective of the patient's clinical condition. There was no significant diurnal variation in the value of the ratio. Lowering of this plasma amino acid ratio appears to be secondary to liver disease and quite independent of the presence of hepatic encephalopathy.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 730076      PMCID: PMC1412250          DOI: 10.1136/gut.19.11.1068

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  22 in total

1.  Studies on aromatic amino acid uptake by rat brain in vivo. Uptake of phenylalanine and of tryptophan; inhibition and stereoselectivity in the uptake of tyrosine by brain and muscle.

Authors:  G GUROFF; S UDENFRIEND
Journal:  J Biol Chem       Date:  1962-03       Impact factor: 5.157

2.  Role of a false neurotransmitter, octopamine, in the pathogenesis of hepatic and renal encephalopathy.

Authors:  K C Lam; A R Tall; G B Goldstein; S P Mistilis
Journal:  Scand J Gastroenterol       Date:  1973       Impact factor: 2.423

3.  Treatment of hepatic coma and hepatorenal syndrome. Mechanism of action of L-dopa and aramine.

Authors:  J E Fischer; J H James
Journal:  Am J Surg       Date:  1972-02       Impact factor: 2.565

4.  False neurotransmitters and hepatic failure.

Authors:  J E Fischer; R J Baldessarini
Journal:  Lancet       Date:  1971-07-10       Impact factor: 79.321

5.  Serotonin metabolism in rat brain after surgical diversion of the portal venous circulation.

Authors:  R J Baldessarini; J E Fischer
Journal:  Nat New Biol       Date:  1973-09-05

6.  Amino acid and alpha-keto acid concentrations in plasma and blood of the liverless dog.

Authors:  R H McMenamy; J Vang; T Drapanas
Journal:  Am J Physiol       Date:  1965-11

7.  Insulin, glucagon, aminoacid imbalance, and hepatic encephalopathy.

Authors:  P B Soeters; J E Fischer
Journal:  Lancet       Date:  1976-10-23       Impact factor: 79.321

8.  Gamma-glutamyl transpeptidase in brain capillaries: possible site of a blood-brain barrier for amino acids.

Authors:  M Orlowski; G Sessa; J P Green
Journal:  Science       Date:  1974-04-05       Impact factor: 47.728

9.  Urinary and serum octopamine in patients with portal-systemic encephalopathy.

Authors:  K K Manghani; M R Lunzer; B H Billing; S Sherlock
Journal:  Lancet       Date:  1975-11-15       Impact factor: 79.321

10.  Changes in brain amines following portal flow diversion and acute hepatic coma: effects of levodopa (L-dopa) and intestinal sterilization.

Authors:  J E Fischer; J H James; R Baldessarini
Journal:  Surg Forum       Date:  1972
View more
  47 in total

Review 1.  Diet formulation and choice of enteral diet.

Authors:  D B Silk
Journal:  Gut       Date:  1986-11       Impact factor: 23.059

2.  Mesocaval and distal splenorenal shunts: effect on hepatic function, hepatic hemodynamics, and portal systemic encephalopathy.

Authors:  R Herz; H J Halbfass; M Rössle; D Waldmann; W Gerok
Journal:  Klin Wochenschr       Date:  1985-05-02

3.  Amino acids in hepatic coma.

Authors:  J E Fischer
Journal:  Dig Dis Sci       Date:  1982-02       Impact factor: 3.199

Review 4.  Chronic portal systemic encephalopathy: update 1987.

Authors:  S Sherlock
Journal:  Gut       Date:  1987-08       Impact factor: 23.059

5.  Amino acid challenge in patients with cirrhosis and control subjects: ammonia, plasma amino acid and EEG changes.

Authors:  Hanan Al Mardini; Andrew Douglass; Christopher Record
Journal:  Metab Brain Dis       Date:  2006-05-04       Impact factor: 3.584

6.  Visual evoked potential: a diagnostic tool for the assessment of hepatic encephalopathy.

Authors:  M L Zeneroli; G Pinelli; G Gollini; A Penne; E Messori; G Zani; E Ventura
Journal:  Gut       Date:  1984-03       Impact factor: 23.059

7.  Effect of branched chain amino acid infusions on body protein metabolism in cirrhosis of liver.

Authors:  P D Wright; J D Holdsworth; P Dionigi; M B Clague; O F James
Journal:  Gut       Date:  1986-11       Impact factor: 23.059

Review 8.  Branched-chain amino acids and muscle ammonia detoxification in cirrhosis.

Authors:  Gitte Dam; Peter Ott; Niels Kristian Aagaard; Hendrik Vilstrup
Journal:  Metab Brain Dis       Date:  2013-01-15       Impact factor: 3.584

9.  Plasma free amino acid pattern in chronic hepatitis as a sensitive and prognostic index.

Authors:  T Kano; M Nagaki; T Takahashi; H Ohnishi; K Saitoh; K Kimura; Y Muto
Journal:  Gastroenterol Jpn       Date:  1991-06

10.  Current trends in the treatment of hepatic encephalopathy.

Authors:  Mohamad Rasm Al Sibae; Brendan M McGuire
Journal:  Ther Clin Risk Manag       Date:  2009-08-03       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.